European Archives - Page 61 of 1322 - European Medical Journal

Long-Term Outcomes of SIP-BMG for Bladder Neck Stenosis

The subtrigonal inlay patch buccal mucosal graft (SIP-BMG) technique represents one such advancement.

Music Training Benefits Children with ADHD

Children with ADHD often display timing and attentional deficits, including difficulty tracking rhythms and impulsive behaviours.

pancreatic cancer

ESMO 2025: GFH375 Shows Potential Against KRAS G12D Pancreatic Tumours

Early clinical results reveal that the novel KRAS G12D inhibitor GFH375 achieves a 41% response rate and 97% disease control in advanced…

Reducing Postoperative Urinary Retention in Surgery

Several risk factors increase the likelihood of postoperative urinary retention, including general or opioid-based anaesthesia and underlying benign prostatic hyperplasia.

ALS and MS Share Surprising Environmental Patterns

A geographical analysis shows ALS and MS follow nearly identical patterns, suggesting shared environmental influences behind both diseases.

Enhancing PPIE in Allergy Research and Practice

Enhancing PPIE in allergic disease research offers tangible benefits, from improving patient outcomes to ensuring studies align with real-world needs.

NOD1 Signalling in Acute Liver Failure

NOD1 Signalling in Acute Liver Failure

The study examined transcriptome data from patients with HBV-induced acute liver failure and healthy controls, identifying key genes and pathways linked to disease progression.

ESMO

ESMO 2025: DESTINY-Breast11 Trial Results Revealed

The DESTINY-Breast11 phase 3 trial presented at ESMO 2025 revealed that the anthracycline-free neoadjuvant T-DXd-THP regimen achieved a 67.3% pathologic complete response rate.

Mother’s Voice Enhances Development in Premature Babies

Mother’s Voice Enhances Development in Premature Babies

A new trial shows that hearing their mother’s voice helps premature babies build neural connections essential for language.

EACS 2025: Doxy-PEP Cuts Chlamydia and Syphilis Risk in Men Living With HIV

EACS 2025 study shows doxycycline prophylaxis reduced chlamydia and syphilis rates in Swiss men with HIV, with no effect against gonorrhoea.